Sven Lingjaerde
Chief Investment Officer bei Endeavour Vision SA
Ursprung des Netzwerks ersten Grades von Sven Lingjaerde
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Endeavour Vision SA
 Endeavour Vision SA Investment ManagersFinance Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry.
17
| Private Company | Investment Managers | 17 |
Vision Capital Administration LLC
 Vision Capital Administration LLC Investment ManagersFinance Vision Capital Administration LLC (Vision Capital) is a venture capital firm founded in 1997 by Sven Lingjaerde. The firm is headquartered in Burlingame, California, United States.
7
| Private Company | Investment Managers | 7 |
Europe Unlimited SA
 Europe Unlimited SA Miscellaneous Commercial ServicesCommercial Services Europe Unlimited SA provides critical business resources to technology entrepreneurs, corporations, investors and researchers. Its online tool allows customers to connect with investors and entrepreneurs. The company was founded by William Stevens in 1998 and is headquartered in Brussels, Belgium.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
REFERENCE CAPITAL SA
 REFERENCE CAPITAL SA Investment ManagersFinance Genevest Consulting Group SA is an independent Swiss venture capital firm which was founded in 1983 to provide advisory services to institutional investors and high-net worth individuals. Based in Geneva, Genevest operates in close cooperation with Endeavour Vision SA.
4
| Private Company | Investment Managers | 4 |
Vision Capital LP (Europe)
2
| Extinct | Investment Managers | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sven Lingjaerde
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
CeQur SA
 CeQur SA Medical SpecialtiesHealth Technology CeQur SA develops medical devices for diabetes patients. It offers n insulin delivery device that provides three days of consistent, basal insulin deliver along with on-demand bolus insulin. The company was founded by James L. Peterson in January 2008 and is headquartered in Horw, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SYMETIS SA | Biotechnology | Chief Executive Officer Chairman Director/Board Member Chairman | |
Nuvaira, Inc.
 Nuvaira, Inc. Electronic Equipment/InstrumentsElectronic Technology Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member Director/Board Member | |
| École Polytechnique Fédérale de Lausanne | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Graduate Degree | |
| MEDARTIS HOLDING AG | Medical Specialties | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Polares Medical SA
 Polares Medical SA Medical SpecialtiesHealth Technology Polares Medical SA develops medical device. Its device use for treating mitral valve regurgitation. The company is headquartered in Lausanne, Switzerland. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
EuroUS Ventures Management LLC
 EuroUS Ventures Management LLC Investment ManagersFinance EuroUS Ventures Management LLC (EuroUS Ventures Management) is a venture capital firm founded in 2005 by Lucian Wagner. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Director of Finance/CFO | |
| Boston University | College/University | Masters Business Admin Masters Business Admin | |
Kobojo SAS
 Kobojo SAS Packaged SoftwareTechnology Services Kobojo SAS develops RPG games. It caters for mid-core audiences ranging from investors and developers to regular gamers. The firm offers games and applications for social networks that provides user experience as adversaries. The company was founded by Vincent Vergonjeanne and Franck Tetzlaff in 2008 and is headquartered in Paris, France. | Packaged Software | Director/Board Member Director/Board Member | |
Axovan AG
 Axovan AG Miscellaneous Commercial ServicesCommercial Services Axovan AG conducts biopharmaceutical research and develops pharmaceuticals. Active in pharmaceutical research and development, it focuses on the family of drug targets called G protein-coupled receptors (GPCRs), which are involved in a number of pathologies. It has developed a validated GPCR-based chemical library through its proprietary chem-informatics platform AXADDIS. Its lead product, clasozentan, is an intravenous endothelin receptor antagonist optimized for treating cerebral diseases. It is partnering non-core indication projects (pain, metabolic diseases, inflammation) at earlier stages. The company was founded in 2000 and is headquartered in Allschwil, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| Medartis AG | Director/Board Member Director/Board Member | ||
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Drugstore Chains | Chief Executive Officer | |
| Stratec Medical AGs | Corporate Officer/Principal | ||
finance&invest.brussels SA
 finance&invest.brussels SA Investment ManagersFinance finance&invest.brussels SA is a private equity/venture capital firm founded in 1984. finance&invest.brussels SA is headquartered in Brussels. | Investment Managers | Chief Invt Officer-Spezialfond | |
| Kuros Therapeutics AG | Founder | ||
Qgel SA
 Qgel SA BiotechnologyHealth Technology Qgel SA engages in drug discovery. The private company is based in Lausanne, Switzerland. The Swiss company was founded in 2009 by Matthias Lütolf and Colin Sanctuary. Colin Sanctuary has been the CEO since 2009. | Biotechnology | Chairman | |
| Senspec GmbH | Chairman | ||
Lumendi Ltd.
 Lumendi Ltd. Medical SpecialtiesHealth Technology Lumendi Ltd. develops medical devices for the treatment of gastrointestinal conditions. The private company is based in Maidenhead, UK. The British company was founded in 2014 by Peter Johann. Peter Johann has been the CEO since 2014. | Medical Specialties | Director of Finance/CFO | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member | |
| Nexmed Holding AG | Chairman | ||
| Simon Kenton Council Boy Scouts of America | Corporate Officer/Principal | ||
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Corporate Officer/Principal | |
| Le Grand Hotel Chandolin SA | Chairman | ||
| Kellogg School of Management | College/University | Masters Business Admin | |
Kuros Biosciences AG
 Kuros Biosciences AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosciences AG is a Swiss company that specializes in developing innovative solutions for targeted and controlled bone healing. The private company is based in Schlieren, Switzerland. The company's mission is to eliminate non-unions and improve patient rehabilitation. | Miscellaneous Commercial Services | Director/Board Member | |
| Protek AG | Sales & Marketing | ||
| Stanford University | College/University | Undergraduate Degree | |
Vivaldi Biosciences AG
 Vivaldi Biosciences AG BiotechnologyHealth Technology Vivaldi Biosciences AG is a venture-backed company that focuses on research and development. It develops genetically engineered intranasal vaccines for epidemic and pandemic viral respiratory diseases. The company is headquartered in Vienna, Austria. | Biotechnology | Private Equity Investor | |
Alternative Power Generation
 Alternative Power Generation Engineering & ConstructionIndustrial Services Alternative Power Generation designs and installs solar panels. The private company is based in Irvine, CA. | Engineering & Construction | Director of Finance/CFO | |
| Graduate School of Business Administration Zürich | College/University | Masters Business Admin | |
| SEQUANS COMMUNICATIONS S.A. | Semiconductors | Director/Board Member | |
Creabilis UK Ltd.
 Creabilis UK Ltd. BiotechnologyHealth Technology Part of Sienna Biopharmaceuticals, Inc., Creabilis UK Ltd. engages in research and development of biological products. The company is based in Canterbury, UK. | Biotechnology | Director/Board Member | |
| University of Lausanne | College/University | Graduate Degree | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Chairman | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member | |
| NeoMed S.à.r.l. | Investment Managers | Private Equity Investor | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Chairman |
Statistik
International
| Schweiz | 25 |
| Vereinigte Staaten | 13 |
| Frankreich | 5 |
| Deutschland | 4 |
| Vereinigtes Königreich | 4 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 11 |
| Finance | 6 |
| Commercial Services | 4 |
| Electronic Technology | 3 |
Operativ
| Director/Board Member | 127 |
| Corporate Officer/Principal | 43 |
| Private Equity Investor | 41 |
| Chairman | 28 |
| Undergraduate Degree | 20 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Claudio Nessi | 25 |
| Dominik Ellenrieder | 20 |
| Damien Tappy | 19 |
| Sai Keung Liu | 18 |
| Matthew Constantino | 18 |
| Dag M. Syrrist | 16 |
| Dominique Pitteloud | 14 |
| Patrick Polak | 13 |
| Alexander Schmitz | 13 |
| Robert O’Holla | 13 |
| Bernard Vogel | 12 |
| Jacques R. Essinger | 12 |
| Katie Ellias | 11 |
| Eric P. Milledge | 10 |
| William Wick | 10 |
- Börse
- Insiders
- Sven Lingjaerde
- Unternehmensverbindungen
